3 Reasons to Avoid ACM and 1 Stock to Buy Instead
Since September 2024, AECOM has been in a holding pattern, posting a small return of 0.8% while floating around $96.60.
3 Reasons MTH is Risky and 1 Stock to Buy Instead
Meritage Homes’s stock price has taken a beating over the past six months, shedding 22.2% of its value and falling to $74.61 per share. This may have investors wondering how to approach the situation.
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead
Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the last six months while the S&P 500 has gained 1.6%.
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers.
Q4 Rundown: The RealReal (NASDAQ:REAL) Vs Other Online Marketplace Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the online marketplace stocks, including The RealReal (NASDAQ:REAL) and its peers.
Professional Tools and Equipment Stocks Q4 Teardown: Fortive (NYSE:FTV) Vs The Rest
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the professional tools and equipment industry, including Fortive (NYSE:FTV) and its peers.
2 Reasons to Sell TXG and 1 Stock to Buy Instead
What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad Genetics (NASDAQ:MYGN).
Gas and Liquid Handling Stocks Q4 In Review: Flowserve (NYSE:FLS) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Flowserve (NYSE:FLS) and the rest of the gas and liquid handling stocks fared in Q4.
Thailand Offers Tax Incentives to Bolster Slumping Stocks
(Bloomberg) -- Thailand will provide tax incentives for investments in the nation’s equity market that has underperformed peers this year amid foreign outflows. Most Read from BloombergNJ College to Merge With State School After Financial StressNYC Congestion Pricing Toll Gains Support Among City ResidentsBuffalo’s Billion-Dollar Freeway Fix Is on Ice, But Not Because of TrumpWhere New York City's Zoning Reform Will Add HousingInside the ‘Not Architecture’ of High Line Designers Diller Scofidio